Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 5
2004 5
2005 1
2006 4
2007 3
2008 4
2009 3
2010 1
2011 1
2012 2
2013 2
2014 6
2015 6
2016 7
2017 3
2018 3
2019 6
2020 8
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

71 results
Results by year
Filters applied: . Clear all
Page 1
Parkinson's disease biomarkers based on α-synuclein.
Fayyad M, Salim S, Majbour N, Erskine D, Stoops E, Mollenhauer B, El-Agnaf OMA. Fayyad M, et al. Among authors: el agnaf oma. J Neurochem. 2019 Sep;150(5):626-636. doi: 10.1111/jnc.14809. Epub 2019 Jul 28. J Neurochem. 2019. PMID: 31265130 Free article. Review.
Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration.
Duffy MF, Collier TJ, Patterson JR, Kemp CJ, Luk KC, Tansey MG, Paumier KL, Kanaan NM, Fischer DL, Polinski NK, Barth OL, Howe JW, Vaikath NN, Majbour NK, El-Agnaf OMA, Sortwell CE. Duffy MF, et al. Among authors: el agnaf oma. J Neuroinflammation. 2018 May 1;15(1):129. doi: 10.1186/s12974-018-1171-z. J Neuroinflammation. 2018. PMID: 29716614 Free PMC article.
Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates.
Arotcarena ML, Dovero S, Prigent A, Bourdenx M, Camus S, Porras G, Thiolat ML, Tasselli M, Aubert P, Kruse N, Mollenhauer B, Trigo Damas I, Estrada C, Garcia-Carrillo N, Vaikath NN, El-Agnaf OMA, Herrero MT, Vila M, Obeso JA, Derkinderen P, Dehay B, Bezard E. Arotcarena ML, et al. Among authors: el agnaf oma. Brain. 2020 May 1;143(5):1462-1475. doi: 10.1093/brain/awaa096. Brain. 2020. PMID: 32380543
α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
Taguchi T, Ikuno M, Hondo M, Parajuli LK, Taguchi K, Ueda J, Sawamura M, Okuda S, Nakanishi E, Hara J, Uemura N, Hatanaka Y, Ayaki T, Matsuzawa S, Tanaka M, El-Agnaf OMA, Koike M, Yanagisawa M, Uemura MT, Yamakado H, Takahashi R. Taguchi T, et al. Among authors: el agnaf oma. Brain. 2020 Jan 1;143(1):249-265. doi: 10.1093/brain/awz380. Brain. 2020. PMID: 31816026
Antibodies against alpha-synuclein: tools and therapies.
Vaikath NN, Hmila I, Gupta V, Erskine D, Ingelsson M, El-Agnaf OMA. Vaikath NN, et al. Among authors: el agnaf oma. J Neurochem. 2019 Sep;150(5):612-625. doi: 10.1111/jnc.14713. Epub 2019 Jun 25. J Neurochem. 2019. PMID: 31055836 Free article. Review.
α-Synuclein aggregation and modulating factors.
Paleologou KE, El-Agnaf OM. Paleologou KE, et al. Among authors: el agnaf om. Subcell Biochem. 2012;65:109-64. doi: 10.1007/978-94-007-5416-4_6. Subcell Biochem. 2012. PMID: 23225002 Review.
Glycation in Parkinson's disease and Alzheimer's disease.
Vicente Miranda H, El-Agnaf OM, Outeiro TF. Vicente Miranda H, et al. Among authors: el agnaf om. Mov Disord. 2016 Jun;31(6):782-90. doi: 10.1002/mds.26566. Epub 2016 Mar 4. Mov Disord. 2016. PMID: 26946341 Review.
Gamma-synuclein and the progression of cancer.
Ahmad M, Attoub S, Singh MN, Martin FL, El-Agnaf OM. Ahmad M, et al. Among authors: el agnaf om. FASEB J. 2007 Nov;21(13):3419-30. doi: 10.1096/fj.07-8379rev. Epub 2007 Jun 12. FASEB J. 2007. PMID: 17567567 Review.
71 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page